These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2530403)

  • 1. Testosterone-estradiol binding globulin (TeBG) in hirsute patients treated with cyproterone acetate (CPA) and percutaneous estradiol.
    Vincens M; Mercier-Bodard C; Mowszowicz I; Kuttenn F; Mauvais-Jarvis P
    J Steroid Biochem; 1989 Oct; 33(4A):531-4. PubMed ID: 2530403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen metabolism in hirsute patients treated with cyproterone acetate.
    Mowszowicz I; Wright F; Vincens M; Rigaud C; Nahoul K; Mavier P; Guillemant S; Kuttenn F; Mauvais-Jarvis P
    J Steroid Biochem; 1984 Mar; 20(3):757-61. PubMed ID: 6231428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination of cyproterone acetate and natural estrogens in the treatment of hirsutism].
    Pugeat M; Nicolas MH; Déchaud H; Elmidani M
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(8):1057-62. PubMed ID: 1839798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The mechanism of action of cyproterone acetate in the treatment of hirsutism].
    Rigaud C; Vincens M; Mowszowicz I; Wright F; Mavier P; Nahoul K; Guillemant S; Kuttenn F; Mauvais-Jarvis P
    Ann Endocrinol (Paris); 1983; 44(6):387-92. PubMed ID: 6234849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of hirsutism with cyproterone acetate and percutaneous estradiol].
    Rigaud C; Vincens M; Giacomini P; Kuttenn F; Mauvais-Jarvis P
    Presse Med; 1983 Jan; 12(2):73-6. PubMed ID: 6221318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol.
    Kuttenn F; Rigaud C; Wright F; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1107-11. PubMed ID: 6448264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hirsutism by an association of oral cyproterone acetate and transdermal 17 beta-estradiol.
    Jasonni VM; Bulletti C; Naldi S; Di Cosmo E; Cappuccini F; Flamigni C
    Fertil Steril; 1991 Apr; 55(4):742-5. PubMed ID: 1826278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
    Frölich M; Lachinsky N; Moolenaar AJ
    Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monthly cyproterone acetate in the treatment of hirsute women: clinical and laboratory effects.
    Marcondes JA; Wajchenberg BL; Abujamra AC; Luthold WW; Samojlik E; Kirschner MA
    Fertil Steril; 1990 Jan; 53(1):40-4. PubMed ID: 2136835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism.
    Sahin Y; Bayram F; Keleştimur F; Müderris I
    J Endocrinol Invest; 1998 Jun; 21(6):348-52. PubMed ID: 9699125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
    Barth JH; Cherry CA; Wojnarowska F; Dawber RP
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):5-10. PubMed ID: 1832346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen levels during cyproterone acetate and ethinyl oestradiol treatment of hirsutism.
    Rubens R
    Clin Endocrinol (Oxf); 1984 Mar; 20(3):313-25. PubMed ID: 6233049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cyproterone acetate. 15 cases of hirsutism treated for 1 year].
    Houdent C; Kuhn JM; Balacheff O; Leclerc P; Legrand A; Wolf LM
    Ann Endocrinol (Paris); 1983; 44(6):397-401. PubMed ID: 6234850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hair growth and androgen responses in hirsute women treated with continuous cyproterone acetate and cyclical ethinyl oestradiol.
    Jones DB; Ibraham I; Edwards CR
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):497-501. PubMed ID: 2962412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spironolactone as a single agent for long-term therapy of hirsute patients.
    Spritzer PM; Lisboa KO; Mattiello S; Lhullier F
    Clin Endocrinol (Oxf); 2000 May; 52(5):587-94. PubMed ID: 10792338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone : testosterone estradiol binding globulin ratio in evaluating hirsute women.
    Badawy SZ; Cittadino R; Marshall L
    Int J Fertil; 1982; 27(3):166-70. PubMed ID: 6128322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of long-term treatment with cyproterone acetate or a cyproterone acetate-ethinyl oestradiol combination on androgen levels in blood of hirsute women.
    Frölich M; Vader HL; Walma ST; De Rooy HA
    J Steroid Biochem; 1980 Jan; 12():499-501. PubMed ID: 6448324
    [No Abstract]   [Full Text] [Related]  

  • 18. Impaired pregnenolone secretion after combined cyproterone acetate and ethynyl estradiol therapy in hirsute patients.
    Inaudi P; D'Ambrogio G; Massafra C; Facchini V; Genazzani AR
    Gynecol Obstet Invest; 1982; 14(2):106-20. PubMed ID: 6288518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission.
    Carmina E; Lobo RA
    Hum Reprod; 1997 Apr; 12(4):663-6. PubMed ID: 9159420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of severe hirsutism resulting from hyperandrogenism with the reverse sequential cyproterone acetate regimen.
    Garner PR; Poznanski N
    J Reprod Med; 1984 Apr; 29(4):232-6. PubMed ID: 6232380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.